1. Possible mechanism for the inhibition of gastric (H+/K+)-adenosine triphosphatase by the proton pump inhibition AG1749;Nagaya;J Pharmac exp Ther,1989
2. Human gastric acid secretion following repeated doses of AG1749;Muller;Aliment Pharmac Ther,1989
3. Antisecretory and antiulcer activities of a novel proton pump inhibitor AG1749 in dogs and rats;Satoh;J Pharmac exp Ther,1989
4. Phase I study of lansoprazole (AG1749) antiulcer agent. Capsule form;Tateno;Rinsho Iyaku,1991